RAPT Therapeutics

SFA Theraputics

This biopharmaceutical company develops oral small-molecule drugs for patients suffering from autoimmune diseases, chronic inflammatory conditions, and various types of liver cancer.

Forward Therapeutics

The company develops oral small-molecule medicines for patients with chronic immunological and inflammatory disorders.

Odyssey Therapeutics

This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.

Principia Biopharma

The company develops oral small molecule therapies for patients with immune-mediated diseases and cancer.

Rapport Therapeutics

This company develops small molecule precision medicines for patients suffering from central nervous system disorders.

Receptos

This biopharmaceutical company develops oral small-molecule therapeutic candidates for patients with immune-mediated conditions including inflammatory bowel disease and relapsing multiple sclerosis.

DICE Therapeutics

This biopharmaceutical company develops oral small molecule medicines for patients with chronic immunological and inflammatory diseases such as psoriasis.

Kartos Therapeutics

This biopharmaceutical company develops oral small-molecule therapeutics to treat blood cancers and solid tumors for patients with unmet clinical needs.